1. INTRODUCTION
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Powers of Buyers
4.3.3. Threat of Substitutes
4.3.4. The Threat of New Entrants
4.3.5. Competitive Rivalry in Industry
4.4. Industry Value Chain Analysis
5. EUROPE OTC DRUG MARKET, BY PRODUCT CATEGORY
5.1. Introduction
5.2. Cold, Cough, and Flu Products
5.3. Analgesic
5.4. Dermatology products
5.5. Gastrointestinal Products
5.6. Vitamin, Minerals, and Supplements
5.7. Weight loss and Dietary Products
5.8. Ophthalmic Products
5.9. Sleep Aids
5.10. Others
6. EUROPE OTC DRUG MARKET, BY ADMINISTRATION
6.1. Introduction
6.2. Oral
6.3. Topical, Nasal, and Others
7. EUROPE OTC DRUG MARKET, BY GEOGRAPHY
7.1. Introduction
7.2. Germany
7.3. France
7.4. United Kingdom
7.5. Spain
7.6. Others
8. Competitive Environment and Analysis
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrative
8.3. Mergers, Acquisition, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. Company Profiles
9.1. Novartis AG
9.2. Sanofi
9.3. Cardinal Health
9.4. Bayer AG
9.5. Johnson & Johnson
9.6. Pfizer
9.7. GlaxoSmithKline plc
9.8. Stada Arzeimittel AG
9.9. Viatris Inc.